These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

591 related articles for article (PubMed ID: 16584444)

  • 1. Preparation of soluble infectious samples from scrapie-infected brain: a new tool to study the clearance of transmissible spongiform encephalopathy agents during plasma fractionation.
    Berardi VA; Cardone F; Valanzano A; Lu M; Pocchiari M
    Transfusion; 2006 Apr; 46(4):652-8. PubMed ID: 16584444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TSE clearance during plasma products separation process by Gradiflow(TM).
    Wang K; Johnson A; Obradovic M; Anderson G; Maclean C; Nair H
    Biologicals; 2005 Jun; 33(2):87-94. PubMed ID: 15939286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Removal of exogenous (spiked) and endogenous prion infectivity from red cells with a new prototype of leukoreduction filter.
    Sowemimo-Coker S; Kascsak R; Kim A; Andrade F; Pesci S; Kascsak R; Meeker C; Carp R; Brown P
    Transfusion; 2005 Dec; 45(12):1839-44. PubMed ID: 16371036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pall leukotrap affinity prion-reduction filter removes exogenous infectious prions and endogenous infectivity from red cell concentrates.
    Sowemimo-Coker SO; Pesci S; Andrade F; Kim A; Kascsak RB; Kascsak RJ; Meeker C; Carp R
    Vox Sang; 2006 May; 90(4):265-75. PubMed ID: 16635068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biology of non-conventional transmissible agents or prions].
    Dormont D
    Rev Neurol (Paris); 1998 Feb; 154(2):142-51. PubMed ID: 9773035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of nanofiltration efficacy in reducing infectivity of centrifuged versus ultracentrifuged 263K scrapie-infected brain homogenates in "spiked" albumin solutions.
    Cardone F; Simoneau S; Arzel A; Puopolo M; Berardi VA; Abdel-Haq H; Galeno R; De Pascalis A; Sbriccoli M; Graziano S; Valanzano A; Porte P; Diringer H; Brown P; Flan B; Pocchiari M
    Transfusion; 2012 May; 52(5):953-62. PubMed ID: 22082124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partitioning of TSE infectivity during ethanol fractionation of human plasma.
    Gregori L; Maring JA; MacAuley C; Dunston B; Rentsch M; Kempf C; Rohwer RG
    Biologicals; 2004 Mar; 32(1):1-10. PubMed ID: 15026020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guanidine hydrochloride extraction and detection of prion proteins in mouse and hamster prion diseases by ELISA.
    Kang SC; Li R; Wang C; Pan T; Liu T; Rubenstein R; Barnard G; Wong BS; Sy MS
    J Pathol; 2003 Apr; 199(4):534-41. PubMed ID: 12635145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term subclinical carrier state precedes scrapie replication and adaptation in a resistant species: analogies to bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease in humans.
    Race R; Raines A; Raymond GJ; Caughey B; Chesebro B
    J Virol; 2001 Nov; 75(21):10106-12. PubMed ID: 11581378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of transmissible spongiform encephalopathy infectivity from human red blood cells with prion protein affinity ligands.
    Gregori L; Lambert BC; Gurgel PV; Gheorghiu L; Edwardson P; Lathrop JT; Macauley C; Carbonell RG; Burton SJ; Hammond D; Rohwer RG
    Transfusion; 2006 Jul; 46(7):1152-61. PubMed ID: 16836562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elimination capacity of a TSE-model agent in the manufacturing process of Alphanate/Fanhdi, a human factor VIII/VWF complex concentrate.
    Diez JM; Caballero S; Belda FJ; Otegui M; Gajardo R; Jorquera JI
    Haemophilia; 2009 Nov; 15(6):1249-57. PubMed ID: 19563480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of protein kinase MARK4 in the brains of experimental scrapie rodents and human prion disease correlates with deposits of PrP(Sc).
    Gong HS; Guo Y; Tian C; Xie WL; Shi Q; Zhang J; Xu Y; Wang SB; Zhang BY; Chen C; Liu Y; Dong XP
    Int J Mol Med; 2012 Sep; 30(3):569-78. PubMed ID: 22692785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmissible spongiform encephalopathies (TSE): minimizing the risk of transmission by biological/biopharmaceutical products: an industry perspective.
    Kozak RW; Golker CF; Stadler P
    Dev Biol Stand; 1996; 88():257-64. PubMed ID: 9119148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of prion reduction filters in decreasing infectivity of ultracentrifuged 263K scrapie-infected brain homogenates in "spiked" human blood and red blood cells.
    Cardone F; Sowemimo-Coker S; Abdel-Haq H; Sbriccoli M; Graziano S; Valanzano A; Berardi VA; Galeno R; Puopolo M; Pocchiari M
    Transfusion; 2014 Apr; 54(4):990-5. PubMed ID: 23915063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current strategies to prevent transmission of prions by human plasma derivatives.
    Burnouf T; Padilla A
    Transfus Clin Biol; 2006 Nov; 13(5):320-8. PubMed ID: 17254822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroinvasion in sheep transmissible spongiform encephalopathies: the role of the haematogenous route.
    Sisó S; Jeffrey M; González L
    Neuropathol Appl Neurobiol; 2009 Jun; 35(3):232-46. PubMed ID: 19473292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prion-removal capacity of chromatographic and ethanol precipitation steps used in the production of albumin and immunoglobulins.
    Thyer J; Unal A; Thomas P; Eaton B; Bhashyam R; Ortenburg J; Uren E; Middleton D; Selleck P; Maher D
    Vox Sang; 2006 Nov; 91(4):292-300. PubMed ID: 17105604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clearance of prions during plasma protein manufacture.
    Burdick MD; Pifat DY; Petteway SR; Cai K
    Transfus Med Rev; 2006 Jan; 20(1):57-62. PubMed ID: 16373188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partitioning of human and sheep forms of the pathogenic prion protein during the purification of therapeutic proteins from human plasma.
    Stenland CJ; Lee DC; Brown P; Petteway SR; Rubenstein R
    Transfusion; 2002 Nov; 42(11):1497-500. PubMed ID: 12421224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.